120 related articles for article (PubMed ID: 25621806)
21. Impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: a retrospective analysis from the Japan Society for Hematopoietic Cell Transplantation.
Kanda J; Ichinohe T; Fuji S; Maeda Y; Ohashi K; Fukuda T; Miyamura K; Iwato K; Eto T; Nakamae H; Kobayashi N; Mori T; Mori S; Morishima Y; Atsuta Y; Kanda Y;
Biol Blood Marrow Transplant; 2015 Feb; 21(2):305-11. PubMed ID: 25464119
[TBL] [Abstract][Full Text] [Related]
22. A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial.
Koreth J; Kim HT; Lange PB; Bindra B; Reynolds CG; Chammas MJ; Armand P; Cutler CS; Ho VT; Glotzbecker B; Nikiforow S; Ritz J; Blazar BR; Soiffer RJ; Antin JH; Alyea EP
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1907-13. PubMed ID: 26055298
[TBL] [Abstract][Full Text] [Related]
23. Dynamic Detection of Anti-Human Leukocyte Antigen (HLA) Antibodies but not HLA-DP Loci Mismatches Can Predict Acute Graft-versus-Host Disease and Overall Survival in HLA 12/12-Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies.
Pan Z; Yuan X; Li Y; Wu X; Zhu W; Bao X; Zhao Q; He J
Biol Blood Marrow Transplant; 2016 Jan; 22(1):86-95. PubMed ID: 26283096
[TBL] [Abstract][Full Text] [Related]
24. The MHC gamma block matching: Impact on unrelated hematopoietic stem cell transplantation outcome.
Maskalan M; Grubic Z; Serventi Seiwerth R; Vrhovac R; Mikulic M; Burek Kamenaric M; Stingl Jankovic K; Durakovic N; Zunec R
Hum Immunol; 2020 Jan; 81(1):12-17. PubMed ID: 31735442
[TBL] [Abstract][Full Text] [Related]
25. [Impact of mismatched HLA on graft-versus-host disease in unrelated stem cell transplantation].
Morishima S
Rinsho Ketsueki; 2018; 59(8):1086-1094. PubMed ID: 30185710
[TBL] [Abstract][Full Text] [Related]
26. Molecular disparity of HLA-DPB1 is associated with the development of subsequent solid cancer after allogeneic hematopoietic stem cell transplantation.
Zou J; Kongtim P; Oran B; Srour SA; Greenbaum U; Carmazzi Y; Rondon G; Ciurea SO; Ma Q; Shpall EJ; Champlin RE; Cao K
Cancer; 2023 Apr; 129(8):1205-1216. PubMed ID: 36738229
[TBL] [Abstract][Full Text] [Related]
27. A single high-resolution HLA mismatch has a similar adverse impact on the outcome of related hematopoietic stem cell transplantation as a single low-resolution HLA mismatch.
Fuji S; Kanda J; Kato S; Ikegame K; Morishima S; Miyamoto T; Hidaka M; Kubo K; Miyamura K; Tsudo M; Kobayashi H; Maesako Y; Eto T; Adachi S; Ichinohe T; Atsuta Y; Kanda Y;
Am J Hematol; 2015 Jul; 90(7):618-23. PubMed ID: 25850370
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors affecting outcome after allogeneic transplantation for hematological malignancies from unrelated donors: results from a randomized trial.
Finke J; Schmoor C; Bethge WA; Ottinger HD; Stelljes M; Zander AR; Volin L; Heim DA; Schwerdtfeger R; Kolbe K; Mayer J; Maertens JA; Linkesch W; Holler E; Koza V; Bornhäuser M; Einsele H; Bertz H; Grishina O; Socié G;
Biol Blood Marrow Transplant; 2012 Nov; 18(11):1716-26. PubMed ID: 22713691
[TBL] [Abstract][Full Text] [Related]
29. A novel approach to human leukocyte antigen-mismatched transplantation in patients with malignant hematological disease.
Huang XJ; Han W; Xu LP; Chen YH; Liu DH; Lu J; Chen H; Zhang YC; Jiang Q; Liu KY; Lu DP
Chin Med J (Engl); 2004 Dec; 117(12):1778-85. PubMed ID: 15603704
[TBL] [Abstract][Full Text] [Related]
30. Predictions in the face of clinical reality: HistoCheck versus high-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease.
Askar M; Sobecks R; Morishima Y; Kawase T; Nowacki A; Makishima H; Maciejewski J
Biol Blood Marrow Transplant; 2011 Sep; 17(9):1409-15. PubMed ID: 21296176
[TBL] [Abstract][Full Text] [Related]
31. Alternative donor strategy in unrelated hematopoietic stem cell transplantation - outcome with mismatched donors.
Grubic Z; Maskalan M; Burek Kamenaric M; Desnica L; Mikulic M; Stingl Jankovic K; Durakovic N; Serventi Seiwerth R; Vrhovac R; Zunec R
Adv Med Sci; 2023 Sep; 68(2):332-340. PubMed ID: 37741003
[TBL] [Abstract][Full Text] [Related]
32. High-risk HLA alleles for severe acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation.
Morishima S; Kashiwase K; Matsuo K; Azuma F; Yabe T; Sato-Otsubo A; Ogawa S; Shiina T; Satake M; Saji H; Kato S; Kodera Y; Sasazuki T; Morishima Y;
Haematologica; 2016 Apr; 101(4):491-8. PubMed ID: 26768690
[TBL] [Abstract][Full Text] [Related]
33. HLA-C and HLA-DQB1 compatibility in unrelated cord blood transplants.
Elia L; Arcese W; Torello M; Iori AP; Guglielmi C; Perrone MP; Screnci M; Sprovieri T; Rapanotti MC; Cimino G
Haematologica; 1999 Jun; 84(6):530-4. PubMed ID: 10366797
[TBL] [Abstract][Full Text] [Related]
34. UGT2B17 minor histocompatibility mismatch and clinical outcome after HLA-identical sibling donor stem cell transplantation.
Santos N; Rodríguez-Romanos R; Nieto JB; Buño I; Vallejo C; Jiménez-Velasco A; Brunet S; Buces E; López-Jiménez J; González M; Ferrá C; Sampol A; de la Cámara R; Martínez C; Gallardo D;
Bone Marrow Transplant; 2016 Jan; 51(1):79-82. PubMed ID: 26367234
[TBL] [Abstract][Full Text] [Related]
35. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
[TBL] [Abstract][Full Text] [Related]
36. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China.
Liu QF; Xu XJ; Chen YK; Sun J; Zhang Y; Fan ZP; Xu D; Jiang QL; Wei YQ; Huang F; Feng R; Liu XL; Xu B; Meng FY
Ann Hematol; 2011 Mar; 90(3):331-41. PubMed ID: 20872002
[TBL] [Abstract][Full Text] [Related]
38. HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry.
Crocchiolo R; Ciceri F; Fleischhauer K; Oneto R; Bruno B; Pollichieni S; Sacchi N; Sormani MP; Fanin R; Bandini G; Bonifazi F; Bosi A; Rambaldi A; Alessandrino PE; Falda M; Bacigalupo A
Bone Marrow Transplant; 2009 Nov; 44(9):571-7. PubMed ID: 19363528
[TBL] [Abstract][Full Text] [Related]
39. Role of HLA in hematopoietic SCT.
Nowak J
Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S71-6. PubMed ID: 18978750
[TBL] [Abstract][Full Text] [Related]
40. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
Ayuk F; Diyachenko G; Zabelina T; Panse J; Wolschke C; Eiermann T; Binder T; Fehse B; Erttmann R; Kabisch H; Bacher U; Kröger N; Zander AR
Exp Hematol; 2008 Aug; 36(8):1047-54. PubMed ID: 18456390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
